Family Medicine Experts & Viewpoints
- Older Women and Fresh Assisted Reproduction Treatment - Success Rates and Cost of a Live Birth
- Apparent Life-Threatening Events Linked to Sudden Infant Death Syndrome?
- URIs and the Development of Acute Otitis Media
- Short vs Long Intravenous Antibiotic Treatment of Acute Pyelonephritis in Children
- Monitoring and Managing Cardiotoxicities Associated with Cancer Therapies: An Expert Interview with Dr. Pamela S. Douglas
- Which Diet is Best? Have the Behaviorists Failed Us?
- Should Statins Ever Be Prescribed in Children With Lipid Problems?
- Why Should I Report an Adverse Drug Event?
- P-4-P? How about P-B4-P?
- Are Osteoporosis Risks Being Overlooked?
POLL
A new bill in Congress would send trained clinicians into doctors’ offices with independent data about the relative benefits, risks, and costs of drugs; some research suggests that such "academic detailing" reduces potential prescribing bias from the influence of drug company reps. What effect do you think such a program would have?